Creo Medical Group PLC CREO
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- GBX 36.25
- Day Range
- GBX 36.00–36.50
- 52-Week Range
- GBX 22.72–50.00
- Bid/Ask
- GBX 0.00 / GBX 0.00
- Market Cap
- GBX 13.10 Bil
- Volume/Avg
- 299,147 / 824,061
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 2.86
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Creo Medical Group PLC is a medical device company engaged in providing services in the field of surgical endoscopy. The company has developed a platform called Croma which is an electrosurgical platform to deliver microwave and bipolar radiofrequency through a single accessory port. The reportable segment of the company is the research and development of electrosurgical medical devices relating to the field of surgical endoscopy.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Core
- Total Number of Employees
- 279
- Website
- https://www.creomedical.com
Comparables
Valuation
|
Metric
|
CREO
|
301033
|
688016
|
|---|---|---|---|
Price/Earnings (Normalized) | — | 96.40 | 26.59 |
Price/Book Value | 2.16 | 3.74 | 3.76 |
Price/Sales | 2.86 | 11.49 | 10.65 |
Price/Cash Flow | — | 26.18 | 22.64 |
Price/Earnings
CREO
301033
688016
Financial Strength
|
Metric
|
CREO
|
301033
|
688016
|
|---|---|---|---|
Quick Ratio | 3.45 | — | — |
Current Ratio | 4.13 | — | — |
Interest Coverage | −97.99 | — | — |
Quick Ratio
CREO
301033
688016
Profitability
|
Metric
|
CREO
|
301033
|
688016
|
|---|---|---|---|
Return on Assets (Normalized) | −27.98% | — | — |
Return on Equity (Normalized) | −46.47% | — | — |
Return on Invested Capital (Normalized) | −33.19% | — | — |
Return on Assets
CREO
301033
688016
Medical Devices Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ABT
| Abbott Laboratories | Txznyckh | Rvjxd | $185.4 Bil | |
SYK
| Stryker Corp | Dsqxjlfrvz | Fhqb | $128.2 Bil | |
BSX
| Boston Scientific Corp | Vhljqrdxx | Vsjwk | $107.7 Bil | |
MDT
| Medtronic PLC | Qvbkfyx | Tqfrvb | $105.2 Bil | |
DXCM
| DexCom Inc | Zgxgqqbv | Kbxv | $54.7 Bil | |
EW
| Edwards Lifesciences Corp | Vsrbjnbt | Qzrvn | $52.8 Bil | |
ZBH
| Zimmer Biomet Holdings Inc | Mhbqpvfkck | Tfrm | $24.6 Bil | |
ALGN
| Align Technology Inc | Psnsngfp | Jnbnsc | $23.4 Bil | |
PHG
| Koninklijke Philips NV ADR | Wxdycqmr | Jnhjcn | $18.7 Bil | |
PODD
| Insulet Corp | Hqjkbgmxy | Zrbcqj | $11.5 Bil |